Clinical trial
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in…
NCT00137358 · University of Alabama at Birmingham, Other · Withdrawn
Key facts
| NCT number | NCT00137358 |
|---|---|
| Title | Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer |
| Official title | Phase I Trial of Dose Escalated IMRT to the Para-aortic Nodes With Concurrent Cisplatin and Amifostine in Locally Advanced Cervical Cancer |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | MedImmune LLC Industry |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Radiation Therapy, Cisplatin, Amifostine |
| Enrollment | 0 |
| First posted | Aug 29, 2005 |
| Last update posted | Jan 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: